1. Dapagliflozin, a type 2 diabetes medication, has shown potential benefits post myocardial infarction

    Dapagliflozin, a type 2 diabetes medication, has shown potential benefits post myocardial infarction

    22
  2. SGLT2 inhibitors Dapagliflozin have shown positive effects on the human heart.

    SGLT2 inhibitors Dapagliflozin have shown positive effects on the human heart.

    70
  3. SGLT2i EXTEND LIFE IN NON-DIABETIC CKD! || SSRIs & Nicotine || NAFLD & Heart Disease || Biomarkers

    SGLT2i EXTEND LIFE IN NON-DIABETIC CKD! || SSRIs & Nicotine || NAFLD & Heart Disease || Biomarkers

    64